Destiny Pharma PLC | Finanzwire

BRIEF

published on 08/20/2024 at 12:57, 4 months 1 day ago

Destiny Pharma to Present XF-73 Nasal Gel Data at ESCMID Conference

Clinical Data Antibiotic Resistance XF-73 Nasal Gel ESCMID Conference Cardiac Surgery
PRESS RELEASE

published on 08/20/2024 at 12:52, 4 months 1 day ago

Destiny Pharma to Deliver Presentation at the European Society of Clinical Microbiology and Infectious Disease conference on XF-73 Nasal Gel and the Use of Post-Operative Antibiotics in Cardio-vascula
Destiny Pharma to deliver presentation on XF-73 Nasal Gel at ESCMID conference highlighting rapid reduction in S. aureus nasal burden and lower need for post-operative antibiotics

Destiny Pharma XF-73 Nasal Gel ESCMID Conference S. Aureus Post-operative Antibiotics
BRIEF

published on 08/14/2024 at 12:25, 4 months 7 days ago

Destiny Pharma Initiates Research to Explore XF Drug Potential for CF

Biotechnology Cystic Fibrosis MRSA Drug Research XF-73
PRESS RELEASE

published on 08/14/2024 at 12:20, 4 months 7 days ago

Destiny Pharma initiates research to explore XF drug potential for CF
Destiny Pharma initiates research to explore XF drug potential for CF. Study focusing on XF-73 to treat MRSA infection in people with cystic fibrosis. Details on the project and potential benefits

Clinical Study Destiny Pharma XF Drug CF Research MRSA Infection
BRIEF

published on 08/13/2024 at 10:41, 4 months 8 days ago

Destiny Pharma plc Shares Now Trading on JP Jenkins

Biotechnology JP Jenkins Share Trading Destiny Pharma Innovative Medicines
PRESS RELEASE

published on 08/13/2024 at 10:36, 4 months 8 days ago

Destiny Pharma plc shares now trading on JP Jenkins
Destiny Pharma plc shares now trading on JP Jenkins. Clinical stage biotechnology company focused on preventing & curing infections. Shares admitted to JP Jenkins trading platform

Shares Biotechnology JP Jenkins Trading Platform Destiny Pharma Plc

Published on 12/21/2024 at 01:30, 17 hours 32 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 32 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 57 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 2 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 32 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 18 hours 11 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 17 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 52 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 6 hours 45 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 5 hours ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News